| Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders |
Globe Newswire |
06/22 |
08:00 |
| NordLayer Named a Winner in the Expert Insights Cybersecurity Awards Summer 2026 for Network Security |
Globe Newswire |
06/22 |
08:00 |
| Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion |
Globe Newswire |
06/22 |
08:00 |
| Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome |
Globe Newswire |
06/22 |
08:00 |
| Amaero Expands Powder Capacity Ahead of Schedule |
Globe Newswire |
06/22 |
08:00 |
| Castor Maritime Inc. Announces Vessel Acquisition |
Globe Newswire |
06/22 |
07:45 |
| Irby Celebrates 100 Years of Growth, Partnership and Industry Leadership |
Globe Newswire |
06/22 |
07:41 |
| Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds |
Globe Newswire |
06/22 |
07:30 |
| Quantum Cyber Issues Letter to Shareholders |
Globe Newswire |
06/22 |
07:30 |
| BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives |
Globe Newswire |
06/22 |
07:30 |
| FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations |
Globe Newswire |
06/22 |
07:30 |
| SL Green Realty Corp. to Release Second Quarter 2026 Financial Results After Market Close on July 22, 2026 |
Globe Newswire |
06/22 |
07:30 |
| Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 |
Globe Newswire |
06/22 |
07:30 |
| Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY |
Globe Newswire |
06/22 |
07:30 |
| New 'Your Year' Planners Team Up with Zebra Pen Ahead of the Back-to-School Season |
Globe Newswire |
06/22 |
07:30 |
| AP Decision Notes: What to expect in Maryland’s state primary |
AP Online |
06/22 |
07:19 |
| CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies |
Globe Newswire |
06/22 |
07:04 |
| TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation |
Globe Newswire |
06/22 |
07:00 |
| Sparklight Strengthens Local Communities through More than $125,000 in Charitable Giving Fund Grants |
Globe Newswire |
06/22 |
07:00 |
| Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031 |
Globe Newswire |
06/22 |
07:00 |
| Brunswick Corporation Announces Operational Updates at Lowell Facility |
Globe Newswire |
06/22 |
07:00 |
| Robinhood Announces Private Offering of $2.0 Billion of Convertible Senior Notes Due 2029 |
Globe Newswire |
06/22 |
07:00 |
| Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) |
Globe Newswire |
06/22 |
07:00 |
| Digital Realty Announces Transactions to Drive Continued Platform Growth |
Globe Newswire |
06/22 |
07:00 |
| Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program |
Globe Newswire |
06/22 |
07:00 |
